Background and Objective: Given the large numbers of open breast biopsies performed in women who have benign breast masses, we developed a clinical decision rule (CDR), called BREASTAID, to triage women into open biopsy or follow-up.
Methods: A prospective cohort design was used to obtain data on 452 palpable breast masses evaluated at a referral clinic. Breast cancer was defined as ductal carcinoma in situ or invasive cancer at open biopsy. Separate logistic regression models were developed at three logical stages of the clinical workup. Bayes' theorem was applied in a stepwise fashion to revise model probabilities to generate a final probability of cancer. Receiver operator characteristics curves were generated to determine the optimum cut-point. Results derived from the CDR were compared with actual clinical practice.
Results: A total of 452 masses in 380 women were included. Clinical practice resulted in 180 masses (39.8%) undergoing open biopsy, 41 (22.8%) of which were cancers. Age, history of breast cancer in the mother, mass size, mammography findings, and fine needle aspiration biopsy results were included in the final models. When applied to the derivation dataset, BREASTAID successfully identified 40 of 41 cancer masses (sensitivity 97.6%, 95% confidence interval [CI] 94.1–99.9), and 350 of 411 noncancer masses (specificity 85.2%, 95% CI 81.8–88.5). BREASTAID would have reduced the number of biopsies performed on the 411 benign masses from 139 to 61.
Conclusions: This study demonstrated that a CDR based on routinely collected clinical variables has the potential to accurately triage women with palpable breast masses. Further validation of the rule is required before its clinical use can be considered.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Clinical Epidemiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Clinical diagnosis of breast cancer.J Reprod Med. 1975; 14: 231-240
- Evaluation of a palpable breast mass.N Engl J Med. 1992; 327: 937-942
- Diagnostic efficacy of physical examination, mammography, fine needle aspiration cytology (triple-test) in solid breast lumps: an analysis of 1708 consecutive cases.Tumori. 1990; 76: 476-479
- Assessment of a scoring scheme for the preoperative diagnosis of breast lumps.Ann R Coll Surg Engl. 1984; 66: 267-269
- Diagnostic efficacy of the clinical-radiological-cytological triad in solid breast lumps: results of a second prospective study on 631 patients.Eur J Surg Oncol. 1987; 13: 335-340
- Usefulness of Triple Test Score for palpable breast masses.Arch Surg. 2001; 136: 1008-1013
- Clinical prediction rules: application and methodological standards.N Engl J Med. 1985; 313: 793-799
- Clinical prediction rules: a review and suggested modifications of methodological standards.JAMA. 1997; 277: 488-494
- Users' guide to the medical literature. XXII: how to use articles about clinical decision rules.JAMA. 2000; 284: 79-84
- The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.N Engl J Med. 1995; 332: 1589-1593
- American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS®). Third Edition. © American College of Radiology, Reston, VA1998
- Effects of fine needle aspiration on subsequent mammograms.Br J Surg. 1992; 79: 52-54
- Mammography after needle aspiration of palpable breast masses.Am J Surg. 1983; 145: 395
- Biopsy by needle puncture and aspiration.Ann Surg. 1930; 92: 169-181
- ‘Tactile sensation’: a new clinical sign during fine needle aspiration of breast lumps.Ann R Coll Surg Engl. 1994; 76: 136-138
- Kline T.S. Kline I.K. Guides to clinical aspiration biopsy - breast. Igaku-Shoin, New York1989
- The uniform approach to breast fine-needle aspiration biopsy.Diagn Cytopathol. 1997; 16: 295-311
- Kleinbaum D.G. Logistic regression. Springer Verlag, New York1994
- Hosmer D. Lemeshow S. Applied logistic regression. Wiley Interscience, New York1989
- SAS version 8.02. SAS Institute, Cary (NC)2001
- Sackett D.L. Haynes R.B. Guyatt G.H. Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Little, Brown and Company, Boston1991
- ROCKIT, vol. 2002. Version 0.9B. University of Chicago, Chicago1998
- Epidemiology of benign breast disease, with special attention to histologic types.Epidemiol Rev. 1997; 19: 310-327
Osuch JR, Reeves MJ, Pathak DR, et al. BREASTAID: Clinical results from early development of a clinical decision rule for palpable solid breast masses. Ann Surg, in press.
- Multivariable prognostic models: Issues in developing models, evaluation assumptions and adequacy, and measuring and reducing errors.Stat Med. 1996; 15: 361-387
- Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.J Clin Epidemiol. 2001; 54: 774-781
- Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System.J Natl Cancer Inst. 1998; 90: 1801-1809
- Inter-observer and intra-observer variability of mammogram interpretation: a field study.Eur J Cancer. 1992; 28A: 1054-1058
- The risk of determining risk with multivariable models.Ann Intern Med. 1993; 118: 201-210
- On the use and computation of likelihood ratios in clinical chemistry.Clin Chem. 1982; 28: 1113-1119
- Validation of logistic regression models used in the assessment of prognosis and the need for surgery in equine colic patients.Prev Vet Med. 1992; 13: 155-172
- Modelling result-specific likelihood ratios.J Clin Epidemiol. 1992; 45: 1135-1140
© 2003 Elsevier Inc. Published by Elsevier Inc. All rights reserved.